We at Norameda constantly monitor and analyse the health system and the development of the pharmaceutical market.<\/p>\n
At the moment, the biggest challenge for the European health system \u2013 massive backlogs, generated by the pandemic. There is uncertainty about recovery rates and the time required to clear them. For example, the EU backlog is estimated at ca. 1 bn diagnosis visits.<\/p>\n
\u201cBaltic region is not an exception \u2013 the patient backlog is and will remain the main challenge for the Health Care system. For example, the number of patients with Myocardial infarctions and Bronchial asthma dropped down around 10% in 2020. This is a warning sign of patient backlog\u201d \u2013 says Norameda General Manager Audrius Leiva.<\/p>\n
IQVIA research shows fewer diagnosed Oncology Diabetes and Psychiatry patients (lowest since 2016) as well as a significant drop in number (-20%) of treated patients in 2020 QI compared to 2019 QI\u2013 it can bring challenges for the Health Care system later after Covid pandemic.<\/p>\n
There is an estimate that Central and Eastern Europe will emerge from the pandemic slowly, but steady. Even so, the economic crisis will constrain healthcare budgets and the focus on cost containment will remain and may be exacerbated by the pandemic.<\/p>\n
\u201cOptimistic forecast for Baltic region pharmaceutical market is +6.2% in 2022. The biggest growth is expected in Lithuania, especially in the speciality RX segment (+17,5%)\u201d \u2013 says Audrius Leiva.<\/p>\n
The number of Gx launches was affected by COVID, on average there was a 14% drop in the launches\u2019 count in the 7 markets in 2020. As well as that, the average Gx launch performance was 18% below the pre-COVID level.<\/p>\n
A positive side-effect of COVID \u2013 digitalization of healthcare, including E-commerce and patient interactions: the pandemic boosted e-health, OTC online sales and triggered a discussion about Rx online sales & home deliveries.<\/p>\n
Backlog clearance and vaccine rollout impact healthcare budgets, new product launch strategies and HCPs attention\/availability thus calling for a review of HCP engagement and patient-activation approaches.<\/p>\n
The increasing role of speciality drugs, RWE data for new product development, e-health, OTC online sales and prospects for Rx home delivery drive new business opportunities and future profit pools, especially in e-commerce.<\/p>\n
Changing dynamics and attractiveness of markets, the increasing role of technology and big data analytic triggering differentiated pharma companies approaches and creating window-of-opportunity for fast adopting players to grow.<\/p>\n
The two leading global therapy areas \u2014 Oncology and Immunology \u2014 are forecast to grow 9\u201312% CAGR through 2025.<\/p>\n
Based on the IQVIA report, 5th October 2021<\/strong><\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" The biggest challenge for the European health system \u2013 massive backlogs, generated by the pandemic. There is uncertainty about recovery rates and the time required to clear them. For example, the EU backlog is estimated at ca. 1 bn diagnosis visits.<\/p>\n","protected":false},"author":220,"featured_media":7405,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_links_to":"","_links_to_target":""},"categories":[136],"tags":[],"_links":{"self":[{"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/posts\/7399"}],"collection":[{"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/users\/220"}],"replies":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/comments?post=7399"}],"version-history":[{"count":3,"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/posts\/7399\/revisions"}],"predecessor-version":[{"id":7412,"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/posts\/7399\/revisions\/7412"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/media\/7405"}],"wp:attachment":[{"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/media?parent=7399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/categories?post=7399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.norameda.com\/en\/wp-json\/wp\/v2\/tags?post=7399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}